Research Paper Volume 16, Issue 17 pp 12312—12334
Identification of a circadian-based prognostic signature predicting cancer-associated fibroblasts infiltration and immunotherapy response in bladder cancer
Figure 7. Different immunotherapy response and chemotherapy sensitivity between high- and low-risk groups. (A) Differences of the TIDE score between high- and low-risk groups, *** p < 0.001. (B–D) Relationship of risk score with immunotherapy efficiency in IMvigor210 cohort. (B) Difference of risk score in different response groups. (C) Distribution of different response in high- and low-risk groups. (D) Kaplan-Meier curve of the high- and low-risk patients. (E) The estimated IC50 of chemotherapy drugs.